Visone et al. reported that miR-221 and miR-222 regulate the cell cycle by targeting p27Kip1 in human thyroid papillary carcinomas, while abnormal cell cycle leads to malignant transformation. This evidence concerns the gene CDKN1B and differentiated thyroid carcinoma.